Aion Therapeutic Stock Analysis
| ANTCF Stock | USD 0 0.00 0.00% |
Aion Therapeutic holds a debt-to-equity ratio of 0.135. Aion Therapeutic's financial risk is the risk to Aion Therapeutic stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Aion Therapeutic's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Aion Therapeutic's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Aion Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Aion Therapeutic's stakeholders.
For most companies, including Aion Therapeutic, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Aion Therapeutic, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Aion Therapeutic's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Aion Therapeutic's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Aion Therapeutic is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Aion Therapeutic to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Aion Therapeutic is said to be less leveraged. If creditors hold a majority of Aion Therapeutic's assets, the Company is said to be highly leveraged.
Aion Therapeutic is undervalued with Real Value of 0.00373 and Hype Value of 0.001639. The main objective of Aion Therapeutic pink sheet analysis is to determine its intrinsic value, which is an estimate of what Aion Therapeutic is worth, separate from its market price. There are two main types of Aion Therapeutic's stock analysis: fundamental analysis and technical analysis.
The Aion Therapeutic pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Aion Therapeutic's ongoing operational relationships across important fundamental and technical indicators.
Aion |
Aion Pink Sheet Analysis Notes
About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.04. Aion Therapeutic had not issued any dividends in recent years. Aion Therapeutic Inc., a pharmaceutical company, offer medical cannabis products in Canada. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada. Aion Therapeutic is traded on OTC Exchange in the United States.The quote for Aion Therapeutic is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Aion Therapeutic please contact Graham Simmonds at 416 460 3000 or go to https://www.aiontherapeutic.com.Aion Therapeutic Investment Alerts
| Aion Therapeutic is way too risky over 90 days horizon | |
| Aion Therapeutic has some characteristics of a very speculative penny stock | |
| Aion Therapeutic appears to be risky and price may revert if volatility continues | |
| Aion Therapeutic has high likelihood to experience some financial distress in the next 2 years | |
| Aion Therapeutic has accumulated 643.8 K in total debt with debt to equity ratio (D/E) of 0.14, which may suggest the company is not taking enough advantage from borrowing. Aion Therapeutic has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Aion Therapeutic until it has trouble settling it off, either with new capital or with free cash flow. So, Aion Therapeutic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aion Therapeutic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aion to invest in growth at high rates of return. When we think about Aion Therapeutic's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.82 M) with loss before overhead, payroll, taxes, and interest of (1.5 K). | |
| Aion Therapeutic has accumulated about 1.85 K in cash with (1.35 M) of positive cash flow from operations. | |
| Roughly 18.0% of Aion Therapeutic shares are held by company insiders |
Aion Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aion Therapeutic's market, we take the total number of its shares issued and multiply it by Aion Therapeutic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 10th of January, Aion Therapeutic shows the Mean Deviation of 56.53, standard deviation of 166.88, and Risk Adjusted Performance of 0.1262. Aion Therapeutic technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Aion Therapeutic variance and maximum drawdown to decide if Aion Therapeutic is priced correctly, providing market reflects its regular price of 0.0017 per share. As Aion Therapeutic appears to be a penny stock we also recommend to validate its information ratio numbers.Aion Therapeutic Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Weighted Moving Average calculates a weight for each value in Aion Therapeutic price series with the more recent values given greater weights.
Aion Therapeutic Outstanding Bonds
Aion Therapeutic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aion Therapeutic uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aion bonds can be classified according to their maturity, which is the date when Aion Therapeutic has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Aion Therapeutic Predictive Daily Indicators
Aion Therapeutic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aion Therapeutic pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0017 | |||
| Day Typical Price | 0.0017 |
Aion Therapeutic Forecast Models
Aion Therapeutic's time-series forecasting models are one of many Aion Therapeutic's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aion Therapeutic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Aion Therapeutic Debt to Cash Allocation
Many companies such as Aion Therapeutic, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Aion Therapeutic has accumulated 643.8 K in total debt with debt to equity ratio (D/E) of 0.14, which may suggest the company is not taking enough advantage from borrowing. Aion Therapeutic has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Aion Therapeutic until it has trouble settling it off, either with new capital or with free cash flow. So, Aion Therapeutic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aion Therapeutic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aion to invest in growth at high rates of return. When we think about Aion Therapeutic's use of debt, we should always consider it together with cash and equity.Aion Therapeutic Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Aion Therapeutic's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Aion Therapeutic, which in turn will lower the firm's financial flexibility.Aion Therapeutic Corporate Bonds Issued
Most Aion bonds can be classified according to their maturity, which is the date when Aion Therapeutic has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Aion Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Aion Therapeutic prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aion shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Aion Therapeutic. By using and applying Aion Pink Sheet analysis, traders can create a robust methodology for identifying Aion entry and exit points for their positions.
Aion Therapeutic Inc., a pharmaceutical company, offer medical cannabis products in Canada. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada. Aion Therapeutic is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Aion Therapeutic to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Complementary Tools for Aion Pink Sheet analysis
When running Aion Therapeutic's price analysis, check to measure Aion Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aion Therapeutic is operating at the current time. Most of Aion Therapeutic's value examination focuses on studying past and present price action to predict the probability of Aion Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aion Therapeutic's price. Additionally, you may evaluate how the addition of Aion Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |